0
     

Report Added
Report already added
NRT Smoking Cessation Aids in the Czech Republic

NRT Smoking Cessation Aids in the Czech Republic

In 2021, nearly a quarter of the over-15 population of the Czech Republic were smokers, though there was a small decline when compared with 2020. Three-quarters of these people were daily smokers, with a greater proportion of men than women being daily smokers. The introduction of the anti-smoking law, better prevention, higher health literacy and lifestyle changes are contributing to the continued decline in smokers, with this thanks to Czechs responding to information about the risks of smokin...

Euromonitor International's NRT Smoking Cessation Aids in Czech Republic report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.

Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the NRT Smoking Cessation Aids market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
NRT Smoking Cessation Aids in the Czech Republic

List Of Contents And Tables

NRT SMOKING CESSATION AIDS IN THE CZECH REPUBLIC
KEY DATA FINDINGS
2022 DEVELOPMENTS
The number of smokers in the Czech Republic continues to decline as financial incentives encourage them to quit
Increased switch towards alternative tobacco products is limiting growth of NRT smoking cessation aids
E-commerce sales remain somewhat limited as pharmacies are preferred
PROSPECTS AND OPPORTUNITIES
Health trend and economic incentives will bolster smokers’ commitment to quitting
Category growth to be hampered by shift towards alternative smoking products
NRT smoking cessation aids to continue concentrated around two brands
CATEGORY INDICATORS
Table 1 Number of Smokers by Gender 2017-2022
CATEGORY DATA
Table 2 Sales of NRT Smoking Cessation Aids by Category: Value 2017-2022
Table 3 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2017-2022
Table 4 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2018-2022
Table 5 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2019-2022
Table 6 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2022-2027
Table 7 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2022-2027
CONSUMER HEALTH IN THE CZECH REPUBLIC
EXECUTIVE SUMMARY
Consumer health in 2022: The big picture
2022 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
Table 9 Life Expectancy at Birth 2017-2022
MARKET DATA
Table 10 Sales of Consumer Health by Category: Value 2017-2022
Table 11 Sales of Consumer Health by Category: % Value Growth 2017-2022
Table 12 NBO Company Shares of Consumer Health: % Value 2018-2022
Table 13 LBN Brand Shares of Consumer Health: % Value 2019-2022
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2017-2022
Table 15 Distribution of Consumer Health by Format: % Value 2017-2022
Table 16 Distribution of Consumer Health by Format and Category: % Value 2022
Table 17 Forecast Sales of Consumer Health by Category: Value 2022-2027
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
Summary 1 OTC: Switches 2021-2022
DISCLAIMER
DEFINITIONS
SOURCES
Summary 2 Research Sources

Report Title: NRT Smoking Cessation Aids in the Czech Republic


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

2023 What's Next for Vietnam Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Vietnam Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Venezuela Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Venezuela Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for US Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for US Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Uruguay Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Uruguay Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for United Arab Emirates Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for United Arab Emirates Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Ukraine Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Ukraine Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM